Concord Biotech Limited (CONCORDBIO.BO)

INR 2153.4

(-1.05%)

Operating Expenses Summary of Concord Biotech Limited

  • Concord Biotech Limited's latest annual operating expenses in 2023 was 1.45 Billion INR , down -29.1% from previous year.
  • Concord Biotech Limited's latest quarterly operating expenses in 2024 Q1 was 545.6 Million INR , down -11.83% from previous quarter.
  • Concord Biotech Limited reported a annual operating expenses of 3.28 Billion INR in annual operating expenses 2022, up 11.7% from previous year.
  • Concord Biotech Limited reported a annual operating expenses of 2.94 Billion INR in annual operating expenses 2021, up 63.12% from previous year.
  • Concord Biotech Limited reported a quarterly operating expenses of 2.33 Billion INR for 2023 FY, down -29.1% from previous quarter.
  • Concord Biotech Limited reported a quarterly operating expenses of 1.01 Billion INR for 2023 Q3, down -2.19% from previous quarter.

Annual Operating Expenses Chart of Concord Biotech Limited (2023 - 2019)

Historical Annual Operating Expenses of Concord Biotech Limited (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 1.45 Billion INR -29.1%
2022 3.28 Billion INR 11.7%
2021 2.94 Billion INR 63.12%
2020 1.8 Billion INR 8.66%
2019 1.66 Billion INR 0.0%

Peer Operating Expenses Comparison of Concord Biotech Limited

Name Operating Expenses Operating Expenses Difference
Alfavision Overseas (India) Limited 1.24 Million INR -117617.984%
Biocon Limited 40.9 Billion INR 96.431%
Blue Jet Healthcare Limited 531.85 Million INR -174.458%
Dishman Carbogen Amcis Limited 5.14 Billion INR 71.642%
FERMENTA BIOTECH LIMITED 754.2 Million INR -93.541%
GENOMIC VALLEY BIOTECH LIMITED 375 Thousand INR -389154.133%
Lyka Labs Limited 599.4 Million INR -143.525%
Panacea Biotec Limited 1.99 Billion INR 26.847%
SAMSRITA LABS LIMITED 1.49 Million INR -97383.805%
Servoteach Industries Limited 785.00 INR -185949326.752%
SMS Lifesciences India Limited 602.96 Million INR -142.087%
Supriya Lifescience Limited 1.08 Billion INR -35.139%
Syngene International Limited 5.99 Billion INR 75.651%
TAKE Solutions Limited 396.91 Million INR -267.767%
Titan Biotech Limited 117.05 Million INR -1147.002%
Transgene Biotek Limited 5.39 Million INR -26946.563%
Vanta Bioscience Limited 38.95 Million INR -3646.863%